(TLX) Talanx - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000TLX1005

TLX: Insurance, Reinsurance, Property, Liability, Life, Health

Talanx AG is a leading global insurance and reinsurance provider, headquartered in Hanover, Germany. Established in 1996, the company has built a robust reputation for its comprehensive suite of insurance solutions. Their extensive product range spans life, casualty, liability, motor, aviation, legal protection, and various property insurance offerings, including specialized coverage for fire, theft, and natural disasters. This diverse portfolio underscores their commitment to meeting a wide array of customer needs across different markets and geographies.

In the realm of reinsurance, Talanx demonstrates notable expertise, offering tailored solutions in property, casualty, marine, aviation, credit, and surety. Their agricultural and structured reinsurance products highlight their ability to adapt to evolving market demands. Additionally, their involvement in facultative and natural catastrophe reinsurance, along with a dedicated asset management division, showcases a well-rounded approach to risk management and financial stewardship.

Financially, Talanx AG presents an attractive profile for investors. With a market capitalization of approximately 21.2 billion EUR, the companys size reflects its established presence in the industry. The trailing P/E ratio of 11.2 and a forward P/E of 9.96 suggest a balanced valuation with potential for future growth. The price-to-book ratio of 1.86 indicates a strong balance sheet, while the low price-to-sales ratio of 0.43 points to undervaluation relative to its revenue, making it a compelling option for value-oriented investors.

As a subsidiary of HDI Haftpflichtverband der Deutschen Industrie V.a.G., Talanx leverages a rich history and extensive industry knowledge to maintain its competitive edge. Their strategic focus on operational efficiency and risk management positions them as a stable and forward-thinking player in the global insurance landscape. For investors seeking exposure to a diversified and financially robust insurer with a strong market position, Talanx AG merits serious consideration.

Additional Sources for TLX Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

TLX Stock Overview

Market Cap in USD 27,535m
Sector Financial Services
Industry Insurance - Diversified
GiC Sub-Industry Multi-line Insurance
IPO / Inception

TLX Stock Ratings

Growth 5y 93.5%
Fundamental 41.5%
Dividend 89.5%
Rel. Strength 17.1
Analysts -
Fair Price Momentum 120.00 EUR
Fair Price DCF 754.43 EUR

TLX Dividends

Dividend Yield 12m 5.88%
Yield on Cost 5y 20.52%
Annual Growth 5y 9.39%
Payout Consistency 99.6%

TLX Growth Ratios

Growth Correlation 3m 88.9%
Growth Correlation 12m 86.7%
Growth Correlation 5y 96.9%
CAGR 5y 30.89%
CAGR/Max DD 5y 0.96
Sharpe Ratio 12m 0.48
Alpha 37.74
Beta 0.784
Volatility 21.04%
Current Volume 90.2k
Average Volume 20d 117.5k
What is the price of TLX stocks?
As of April 04, 2025, the stock is trading at EUR 96.40 with a total of 90,207 shares traded.
Over the past week, the price has changed by -2.38%, over one month by +7.11%, over three months by +16.14% and over the past year by +36.16%.
Is Talanx a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Talanx (XETRA:TLX) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.52 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TLX as of April 2025 is 120.00. This means that TLX is currently undervalued and has a potential upside of +24.48% (Margin of Safety).
Is TLX a buy, sell or hold?
Talanx has no consensus analysts rating.
What are the forecast for TLX stock price target?
According to ValueRays Forecast Model, TLX Talanx will be worth about 131.6 in April 2026. The stock is currently trading at 96.40. This means that the stock has a potential upside of +36.5%.
Issuer Forecast Upside
Wallstreet Target Price 85.1 -11.7%
Analysts Target Price - -
ValueRay Target Price 131.6 36.5%